-
UEFA chief Ceferin warns Italy could lose Euro 2032 without stadium improvements
-
Italy's football chief resigns after World Cup disaster
-
Edoardo Molinari named European vice-captain for Ryder Cup
-
'Extraordinary news': Dutch recover stolen gold Romanian helmet
-
France considers reform for New Caledonia
-
UK foreign minister stresses 'urgent need' to reopen Hormuz strait
-
Macron says Trump marriage jibe does not 'merit response'
-
Russia will send second ship with oil to Cuba: minister
-
Belgian bishop takes on Vatican with push to ordain married men
-
Oil rallies, stocks drop as Trump dampens Mideast hopes
-
Nexperia's China unit nears fully local production of chips: company sources
-
Indonesia issues fresh summons for Google, Meta over teen social media ban
-
Japan axe coach Nielsen 12 days after winning Women's Asian Cup
-
French President Macron lands in South Korea after Japan visit
-
India's says defence exports hit 'all-time high' of $4 bn
-
Nielsen leaves as Japan coach weeks after winning Women's Asian Cup
-
Too bright: Seoul to dim digital billboards after complaints
-
Iran vows 'crushing' attacks on US after Trump threats
-
Women's Asian Cup finalists accuse governing body over equal money
-
French president Macron heads to South Korea after Japan visit
-
Armenia's underground salt clinic at centre of alternative medicine debate
-
'Muted' international response as Senegal enacts same-sex relations law
-
Slow boat to Ilulissat: long nights on Greenland's last ferry
-
Wemby rampant again as Spurs rack up 10th straight win
-
Ukrainian death metal band growls against Russia's war
-
Iran fires missiles at Israel after Trump threatens weeks of strikes
-
Surging 'Jewish terrorism' in West Bank condemned but unpunished
-
England's Brook, Bethell warned after New Zealand nightclub incident
-
What's real anymore? AI warps truth of Middle East war
-
Europe to negotiate with NASA on lunar missions: ESA
-
Trump tells US that Iran war victory near, but vows big strikes
-
Poppies offer hope in fire-scarred Los Angeles
-
Trump says Iran war almost over, warns of weeks more heavy strikes
-
Oil rallies, stocks tumble as Trump says US to hammer Iran further
-
US Republicans announce deal to end partial government shutdown
-
Trump tells Americans that Iran war ending as popularity dips
-
7.4-magnitude quake off Indonesia kills one, tsunami warning lifted
-
Bordeaux-Begles' Van Rensburg 'not thinking' about Champions Cup double
-
Valsoft Corporation Strengthens Its Retail Software Portfolio with the Acquisition of NedFox
-
Side-by-Side Conference Hosts Close to 800 Participants in Malta to Advance Women's Health Care
-
U.S. Polo Assn. Supports Division I National Intercollegiate Championship, Showcasing the Future of the Sport of Polo
-
US automakers report mixed sales as car market awaits war impact
-
Astronauts begin NASA lunar mission after climactic blast-off
-
Astronauts blast off for historic US lunar journey
-
Embattled Woods won't captain 2027 Ryder Cup team: PGA of America
-
Judge allows Woods to travel overseas for treatment
-
Chelsea's Bompastor furious as Arsenal reach women's Champions League semis
-
US lifts sanctions on Venezuelan interim leader Delcy Rodriguez
-
Arsenal resist Chelsea rally to reach women's Champions League semis
-
Defending champ Pegula wins WTA Charleston opener
Japan firm probing 76 more deaths in supplement scare
Japanese health supplement maker Kobayashi Pharmaceutical said Friday it was probing 76 more deaths possibly linked to its tablets containing red yeast rice, meant to lower cholesterol.
It deepens a scandal that erupted earlier this year when the company said it was looking into five deaths potentially linked to the over-the-counter products after dozens of customers reported kidney problems.
Fermented with a mould culture, red yeast rice, or "beni koji", has been used in food, alcoholic drinks and folk medicines for centuries around East Asia.
"Even if the direct cause of hospitalisation or death was not kidney-related disease, it has become clear that there are a variety of cases, including cases in which beni koji-related products may have caused harm somehow and had some indirect impact," a Kobayashi statement said.
Of the five initial deaths under investigation, the company said it now knows one did not consume red yeast rice.
"We have received 1,656 inquiries from individuals who have sought medical attention, and have 76 cases under investigation over (a causal) connection to the deaths," in addition to the original four, it said.
On March 22, Kobayashi Pharmaceutical said it was recalling three kinds of tablets containing beni koji.
It later said it had detected a potentially toxic acid produced by the mould at one of its factories, and government officials inspected the firm's facilities.
Kobayashi Pharmaceutical is a household name in Japan, offering a wide range of health-related products, and the scandal has been top news in the country.
On Friday, Kobayashi said it would work to identify the exact cause and scope of the health damage -- including whether organs other than kidneys were harmed.
Top government spokesman Yoshimasa Hayashi said Friday that the health ministry had previously ordered the company to file a daily report on its probe, and demanded more details earlier this month after the number of deaths under investigation didn't change.
"But until today, it had not reported the specific number of cases under investigation, and it is extremely regrettable," Hayashi told reporters.
Kobayashi Pharmaceutical has said it also sold red yeast rice to around 50 other firms in Japan and two in Taiwan.
Taiwanese companies preventively recalled 154 products containing red yeast rice in the wake of the scare, the island's health authorities said earlier this year.
I.Meyer--BTB